Symbicort Related Clinical Trials
A Comparison of Symbicort� Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma [Completed]
Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia [Completed]
Comparing Bronchodilation of Symbicort With and With Out Valved Holding Chamber (Aerochamber Plus) [Recruiting]
Long-Term Safety of Symbicort in Asthmatic Children - SAPLING [Completed]
Atlantis Symbicort [Completed]
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS) [Recruiting]
Gemini Symbicort pMDI [Completed]
Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients [Completed]
Pharmacokinetics and Safety Study of PT010 in Healthy Subjects [Completed]
Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte [Completed]
Symbicort Onset of Action 1 [Completed]
Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER® [Completed]
Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT [Completed]
Phase I Study Evaluating the Safety and Pharmacokinetics of Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (BGF MDI) in Healthy Volunteers [Completed]
An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma [Completed]
Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Patients With Asthma [Completed]
Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD [Completed]
A Safety and Efficacy Study of Symbicort Turbuhaler Compared With Standard Chronic Obstructive Pulmonary Disease (COPD) Treatment in Japan [Completed]
Assess Particle Deposition and Acute Effects of Symbicort® Forte Turbohaler®) in COPD Patients. [Completed]
Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice [Completed]
Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD. [Completed]
Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5 [Completed]
Symbicort Onset of Action 2 [Completed]
Physician and Patient Perception of Adjustable Maintenance Dosing of Symbicort Turbuhaler [Completed]
Titratable Dosing in Moderate to Severe Asthmatics [Completed]
A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics. [Completed]
Symbicort Turbuhaler 30/60 Clinical Experience Investigation [Completed]
Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler [Completed]
A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® [Not yet recruiting]
Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics [Completed]
Symbicort in Asthmatic Children - SEEDLING [Completed]
Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5 [Completed]
Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM [Completed]
Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler [Completed]
Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler [Completed]
A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy [Completed]
Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma [Completed]
A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma [Recruiting]
Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD) [Recruiting]
Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo [Terminated]
Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients [Not yet recruiting]
Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations [Completed]
Symbicort Turbuhaler 30/60 Special Clinical Experience Investigation for Long-term Use for Chronic Obstructive Pulmonary Disease (COPD) Patients [Active, not recruiting]
A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler® [Completed]
SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults [Completed]
DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults [Completed]
Symbicort SMART (Symbicort Maintenance And Reliever Therapy) [Completed]
Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers [Completed]
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma [Completed]
A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART® [Completed]
Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhaler [Completed]
Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma [Completed]
A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler® [Completed]
Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant [Suspended]
Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic [Recruiting]
Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART) [Completed]
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART [Completed]
Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation [Completed]
MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults [Completed]
Symbicort in Chronic Obstruktive Pulmonary Disease [Completed]
Symbicort in Chronic Obstructive Pulmonary Disease [Completed]
Real-world Effectiveness of Combination Therapy in Asthma [Completed]
Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma [Completed]
Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD [Completed]
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma [Recruiting]
Prevention of Asthma Relapse After Discharge From Emergency [Completed]
Airway Clearance Study [Completed]
Evaluation of an Oxygen Enhanced Magnetic Resonance Imaging Method on Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler or Oxis Turbuhaler [Completed]
Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma [Terminated]
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol [Completed]
Pharmacokinetic Pilot Study on Budesonide/Formoterol [Completed]
Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic Subjects [Completed]
Sub-Sensitivity to Long-Acting Bronchodilators (LABA) [Completed]
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma [Recruiting]
Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD) [Completed]
|